-
公开(公告)号:US20180022748A1
公开(公告)日:2018-01-25
申请号:US15547980
申请日:2016-01-29
申请人: UCB Biopharma SPRL
IPC分类号: C07D471/14 , A61K51/04 , C07B59/00
CPC分类号: C07D471/14 , A61K51/0455 , A61K51/0459 , A61K51/0463 , C07B59/002 , C07B2200/05
摘要: The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates.
-
公开(公告)号:US12006316B2
公开(公告)日:2024-06-11
申请号:US17700075
申请日:2022-03-21
申请人: UCB Biopharma SPRL
IPC分类号: C07D471/14 , A61K31/437 , A61K51/04 , C07B59/00
CPC分类号: C07D471/14 , A61K51/0455 , A61K51/0459 , A61K51/0463 , C07B59/002 , C07B2200/05
摘要: The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates.
-
公开(公告)号:US20190106406A1
公开(公告)日:2019-04-11
申请号:US16086698
申请日:2017-04-07
申请人: UCB Biopharma SPRL
发明人: Ali Ates , Eric Jnoff , Laurent Provins , Anne Valade , Adrian Hall
IPC分类号: C07D401/06 , C07D471/04
CPC分类号: C07D401/06 , C07D217/06 , C07D403/06 , C07D471/04
摘要: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
-
公开(公告)号:US20220213103A1
公开(公告)日:2022-07-07
申请号:US17700075
申请日:2022-03-21
申请人: UCB Biopharma SPRL
IPC分类号: C07D471/14 , A61K51/04 , C07B59/00
摘要: The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates.
-
公开(公告)号:US10370355B2
公开(公告)日:2019-08-06
申请号:US16086698
申请日:2017-04-07
申请人: UCB Biopharma SPRL
发明人: Ali Ates , Eric Jnoff , Laurent Provins , Anne Valade , Adrian Hall
IPC分类号: C07D401/06 , C07D471/04
摘要: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
-
-
-
-